Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
{{custom_author.name}}, {{article.zuoZheEn}}
Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 | 〉 |